Bailard’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $353K | Buy |
5,824
+100
| +2% | +$5.83K | 0.01% | 551 |
|
|
2025
Q4 | $309K | Sell |
5,724
-461
| -7% | -$22.2K | 0.01% | 556 |
|
|
2025
Q3 | $279K | Sell |
6,185
-2,241
| -27% | -$105K | 0.01% | 631 |
|
|
2025
Q2 | $390K | Buy |
8,426
+1,266
| +18% | +$62.1K | 0.01% | 547 |
|
|
2025
Q1 | $437K | Buy |
7,160
+1,472
| +26% | +$85.8K | 0.01% | 488 |
|
|
2024
Q4 | $322K | Buy |
5,688
+16
| +0.3% | +$894 | 0.01% | 553 |
|
|
2024
Q3 | $293K | Sell |
5,672
-9,525
| -63% | -$447K | 0.01% | 583 |
|
|
2024
Q2 | $631K | Buy |
15,197
+38
| +0.3% | +$1.7K | 0.02% | 402 |
|
|
2024
Q1 | $822K | Sell |
15,159
-490
| -3% | -$25K | 0.02% | 334 |
|
|
2023
Q4 | $803K | Sell |
15,649
-162,366
| -91% | -$8.52M | 0.02% | 328 |
|
|
2023
Q3 | $10.3M | Buy |
178,015
+640
| +0.4% | +$39.2K | 0.34% | 62 |
|
|
2023
Q2 | $11.3M | Sell |
177,375
-51,367
| -22% | -$3.44M | 0.4% | 57 |
|
|
2023
Q1 | $15.9M | Buy |
228,742
+4,231
| +2% | +$298K | 0.57% | 39 |
|
|
2022
Q4 | $16.2M | Buy |
224,511
+1,789
| +0.8% | +$135K | 0.62% | 37 |
|
|
2022
Q3 | $15.8M | Buy |
222,722
+5,523
| +3% | +$401K | 0.65% | 33 |
|
|
2022
Q2 | $16.7M | Sell |
217,199
-2,048
| -0.9% | -$156K | 0.66% | 32 |
|
|
2022
Q1 | $16M | Buy |
219,247
+4,698
| +2% | +$315K | 0.54% | 41 |
|
|
2021
Q4 | $13.4M | Sell |
214,549
-133
| -0.1% | -$7.8K | 0.43% | 55 |
|
|
2021
Q3 | $12.7M | Sell |
214,682
-2,660
| -1% | -$175K | 0.43% | 53 |
|
|
2021
Q2 | $14.5M | Sell |
217,342
-1,247
| -0.6% | -$81.3K | 0.5% | 42 |
|
|
2021
Q1 | $13.8M | Buy |
218,589
+58,370
| +36% | +$3.63M | 0.51% | 39 |
|
|
2020
Q4 | $9.94M | Buy |
160,219
+569
| +0.4% | +$35K | 0.45% | 50 |
|
|
2020
Q3 | $9.63M | Sell |
159,650
-2,984
| -2% | -$180K | 0.5% | 44 |
|
|
2020
Q2 | $9.56M | Buy |
162,634
+7,601
| +5% | +$455K | 0.53% | 36 |
|
|
2020
Q1 | $8.64M | Buy |
155,033
+8,288
| +6% | +$507K | 0.62% | 31 |
|
|
2019
Q4 | $9.42M | Buy |
146,745
+36,834
| +34% | +$2.11M | 0.53% | 45 |
|
|
2019
Q3 | $5.57M | Sell |
109,911
-64
| -0.1% | -$3.01K | 0.34% | 73 |
|
|
2019
Q2 | $4.99M | Buy |
109,975
+57,021
| +108% | +$2.66M | 0.3% | 76 |
|
|
2019
Q1 | $2.53M | Buy |
52,954
+5,012
| +10% | +$250K | 0.16% | 135 |
|
|
2018
Q4 | $2.49M | Sell |
47,942
-14,166
| -23% | -$761K | 0.17% | 126 |
|
|
2018
Q3 | $3.86M | Sell |
62,108
-4,816
| -7% | -$286K | 0.23% | 97 |
|
|
2018
Q2 | $3.7M | Buy |
66,924
+239
| +0.4% | +$12.9K | 0.22% | 101 |
|
|
2018
Q1 | $4.22M | Buy |
66,685
+1,157
| +2% | +$74.4K | 0.27% | 94 |
|
|
2017
Q4 | $4.02M | Buy |
65,528
+1,415
| +2% | +$88.5K | 0.25% | 96 |
|
|
2017
Q3 | $4.09M | Buy |
64,113
+42,823
| +201% | +$2.5M | 0.32% | 77 |
|
|
2017
Q2 | $1.19M | Sell |
21,290
-776
| -4% | -$42.2K | 0.1% | 164 |
|
|
2017
Q1 | $1.2M | Buy |
22,066
+326
| +1% | +$17.9K | 0.1% | 160 |
|
|
2016
Q4 | $1.27M | Buy |
21,740
+2,152
| +11% | +$118K | 0.12% | 147 |
|
|
2016
Q3 | $1.06M | Sell |
19,588
-446
| -2% | -$28.6K | 0.1% | 160 |
|
|
2016
Q2 | $1.47M | Buy |
20,034
+1,436
| +8% | +$101K | 0.18% | 131 |
|
|
2016
Q1 | $1.19M | Buy |
+18,598
| New | +$1.17M | 0.17% | 95 |
|
|
2015
Q4 | – | Sell |
-19,569
| Closed | -$1.16M | – | 221 |
|
|
2015
Q3 | $1.16M | Sell |
19,569
-1,575
| -7% | -$99.9K | 0.18% | 90 |
|
|
2015
Q2 | $1.41M | Sell |
21,144
-3,758
| -15% | -$248K | 0.22% | 82 |
|
|
2015
Q1 | $1.61M | Sell |
24,902
-1,150
| -4% | -$72K | 0.22% | 82 |
|
|
2014
Q4 | $1.54M | Sell |
26,052
-260
| -1% | -$14.7K | 0.22% | 78 |
|
|
2014
Q3 | $1.35M | Sell |
26,312
-839
| -3% | -$41.9K | 0.21% | 73 |
|
|
2014
Q2 | $1.31M | Sell |
27,151
-1,859
| -6% | -$91.6K | 0.2% | 72 |
|
|
2014
Q1 | $1.51M | Sell |
29,010
-918
| -3% | -$48.8K | 0.24% | 67 |
|
|
2013
Q4 | $1.59M | Sell |
29,928
-2,707
| -8% | -$138K | 0.26% | 63 |
|
|
2013
Q3 | $1.51M | Sell |
32,635
-42,430
| -57% | -$1.86M | 0.29% | 58 |
|
|
2013
Q2 | $3.35M | Buy |
+75,065
| New | +$3.26M | 0.61% | 23 |
|
Other funds holding BMY
VCM
VPM
Bailard's BMY Position: Q1 2026 in Review
Bailard increased its Bristol-Myers Squibb (BMY) stake by 1.7% in Q1 2026, buying an estimated $5.83K and bringing the position to 5,824 shares worth $353K. The position accounts for 0.01% of the portfolio, ranked #551.
Bailard first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $16.7M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Bailard held 5,824 shares of Bristol-Myers Squibb worth $353K as of Q1 2026.
- Bailard bought 100 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.83K.
- Bristol-Myers Squibb made up 0.01% of Bailard's portfolio in Q1 2026, its #551 holding.
- Bailard first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- Bailard's Bristol-Myers Squibb position peaked at $16.7M in Q2 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.